E Journal of Cardiovascular Medicine最新文献

The Tactics of Safe Removal of Heart Myxomas; The Experience of 796 Operations 心脏黏液瘤的安全切除策略796运营的经验

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/EJCM.18.00242

D. Dyadyun, I. Martyshchenko, O. Pishchurin, R. Vitovskiy, V. Isaienko, V. Onishchenko

引用次数: 1

Retrospective Evaluation of the First 150 Patients with Vascular Surgery in A New Cardiovascular Surgery Clinic 一所新开设的心血管外科诊所前150例血管手术患者的回顾性评价

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/ejcm.18.00236

Fatma Tuba İlal Mert, Gökay Altaylı, M. Şahin

{"title":"Retrospective Evaluation of the First 150 Patients with Vascular Surgery in A New Cardiovascular Surgery Clinic","authors":"Fatma Tuba İlal Mert, Gökay Altaylı, M. Şahin","doi":"10.15511/ejcm.18.00236","DOIUrl":"https://doi.org/10.15511/ejcm.18.00236","url":null,"abstract":"Objective: This study aimed to retrospectively evaluate the data of patients undergoing peripheral arterial vascular surgeries and to present our approach to peripheral arterial disease (PAD) in our clinic, which was put into service as of September 2014. \u0000 \u0000Methods: Data on 151 patients undergoing peripheral arterial vascular surgery between September 2014-December 2016 were retrospectively evaluated. Of the patients, 45 (29.80%) underwent emergency surgery and 106 (70.19%) underwent elective surgery. Of emergency surgeries, 31 (68.88%) patients had acute embolism. Among elective surgeries, femoropopliteal bypass was the most common procedure in 52 patients. While above-knee femoropopliteal bypass was performed in 40 (76.92%) patients, vena saphena magna (VSM) could be used as a graft in 31 patients. VSM could be used in 9 of 12 patients undergoing below-knee femoropopliteal bypass. \u0000 \u0000Results: Of 151 patients, 14 (9.27%) were admitted for revision during the postoperative period. Among 52 patients undergoing femoropopliteal bypass, 7 were re-operated (4 underwent above-knee and 3 underwent below-knee femoropopliteal bypass). While the polytetrafluoroethylene graft was used in all of these patients, none of the patients with VSM graft required revision. The patient with Shamblin type-III tumor, who was operated due to glomus caroticum, developed graft occlusion and was re-operated; however, hemiplegia was developed postoperatively. Mortality occurred in 4 patients (2 with abdominal aortic aneurysm rupture and 2 with penetrating injury). All of them had hypovolemic shock prior to the surgery. \u0000 \u0000Conclusion: There is a need for an experienced team for PAD and the treatment method to be applied should be patient-based.","PeriodicalId":315621,"journal":{"name":"E Journal of Cardiovascular Medicine","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122228734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How to make a “Heart Team” a “real” Team to ensure optimal patient care 如何使“心脏团队”成为“真正的”团队，以确保最佳的患者护理

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/EJCM.18.00232

D. Reser, M. Kolbe, J. Pomar, F. Maisano, M. Taramasso

引用次数: 1

The Effect of Benfothiamin and Vitamin D in Ischemia / Reperfusion Model of Rat Skeletal Muscle 苯硫胺和维生素D对大鼠骨骼肌缺血再灌注模型的影响

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/EJCM.18.00252

Ö. Keskin, M. Sipahi, V. Y. Tokgöz, S. Takir, G. Guvendi

{"title":"The Effect of Benfothiamin and Vitamin D in Ischemia / Reperfusion Model of Rat Skeletal Muscle","authors":"Ö. Keskin, M. Sipahi, V. Y. Tokgöz, S. Takir, G. Guvendi","doi":"10.15511/EJCM.18.00252","DOIUrl":"https://doi.org/10.15511/EJCM.18.00252","url":null,"abstract":"Objects: Benfothiamin is a highly potent form of vitamin B1 protecting endothelial function. On the other hand, vitamin D provides restoration of muscular tissue by inhibition of apoptosis and acceleration of cellular proliferation following muscle injury. We assumed that the administration of these vitamins in ischemia/ reperfusion (I/R) injury, could reduce the damage by alteration of the release of various oxidant and antioxidant mediators leading to cellular damage.\u0000\u0000Materials and Methods: We assigned 30 Wistar Albino males rats into 5 groups. In the control group (n=6), rats were anaesthetized and total antioxidant capacity (TAS), total oxidant capacity (TOS), malondialdehyde (MDA), superoxide dismutase (SOD) and nitricoxide (NO) level were measured in lower extremity soleus muscle. Benfotiamin and D were given to the groups and the values of these parameters were evaluated in ischemia reperfusion muscle tissue specimens. All tissues were examined histologically.\u0000\u0000Results: We detected a significant change in groups 3 and 4 for antioxidant NO level after ischemia and reperfusion. Therefore, we observed that the administration of vitamin D and benfothiamin increased NO levels in muscle especially during reperfusion. The level of other oxidants TOS and MDA and antioxidants TAS and SOD were not significant during I/R at given periods. Overall vitamin D and benfothiamin have acute beneficial effects especially in improving I/R injury of lower extremity, even at non-critical periods.\u0000\u0000Conclusion: Acute term effects of benfothiamin and vitamin D can be useful during where changes due to I/R. The effects can be evaluated during long term I/R.","PeriodicalId":315621,"journal":{"name":"E Journal of Cardiovascular Medicine","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128305258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Chronic Leg Ulcer Due to Arteriovenous Malformation: A Case Report 动静脉畸形所致慢性腿部溃疡1例

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/EJCM.18.00276

M. Işık, Yalcin Gunerhan, E. Ege

引用次数: 1

Hybrid Treatment of Supravalvular Aortic Stenosis and Coronary Ostial Stenosis in Familial Hypercholesterolemia 家族性高胆固醇血症患者瓣上主动脉瓣狭窄和冠状动脉口狭窄的综合治疗

E Journal of Cardiovascular Medicine Pub Date : 2018-06-05 DOI: 10.15511/EJCM.18.00268

Ismail Selcuk, M. Uğur, İ. Alp, V. Temizkan, A. Selçuk, Erturk Yedekci, A. Yilmaz

引用次数: 0

Synchronous off-pump Coronary Artery bypass Grafting and Carotid Endarterectomy (an initial experience) 同步非体外循环冠状动脉旁路移植术和颈动脉内膜切除术(初步经验)

E Journal of Cardiovascular Medicine Pub Date : 2018-04-01 DOI: 10.1016/j.amjcard.2018.03.224

A. Abdurakhmanov, M. Obeid, Oybek Mashrapov, N. Rakhimov, U. Ganiev, N. Sultanov, Bakhtiyor P. Khamidov, N. Dadamyants

引用次数: 1

Serum Presepsin Levels in Patients with Decompensated Heart Failure 失代偿性心力衰竭患者血清前高血压素水平

E Journal of Cardiovascular Medicine Pub Date : 2016-11-01 DOI: 10.15836/CCAR2016.525

F. Çağlar, N. Isiksacan, I. Biyik, H. Sahin, Dilay Karakozak, F. Katkat, F. Akturk, Nursel Kocamaz

{"title":"Serum Presepsin Levels in Patients with Decompensated Heart Failure","authors":"F. Çağlar, N. Isiksacan, I. Biyik, H. Sahin, Dilay Karakozak, F. Katkat, F. Akturk, Nursel Kocamaz","doi":"10.15836/CCAR2016.525","DOIUrl":"https://doi.org/10.15836/CCAR2016.525","url":null,"abstract":"Objective: Recently, the soluble CD14 subtype; presepsin (PSP) has been suggested as a reliable marker for systemic inflammation, which has not been studied in decompensated heart failure (DHF) up to date. Our aim was to investigate plasma PSP levels and its diagnostic ability in patients with DHF.\u0000\u0000Methods: Fifty patients with DHF and 51 controls without HF were included in our study. Besides routine clinical and laboratory data, N-terminal prohormone of brain natriuretic peptide (NT-pro BNP) and PSP levels were measured in blood samples of all the participants.\u0000\u0000Results: PSP levels were significantly higher in patients with DHF than controls (1107.98 ± 1001.15 vs. 540.47 ± 526.9 pg / mL, p = 0.001). Cut-off value for PSP was 442 pg / mL to detect HF with 76% sensitivity, 62.7% specificity, 66.7% positive predictive value and 72.7% negative predictive value (CI: 0.975 Â– 1.000). The diagnostic accuracy of PSP for DHF was not superior to that of NT-pro BNP (AUC: 0.99 vs. 0.74)\u0000\u0000Conclusions: This preliminary study reveals that PSP levels are significantly elevated in patients with DHF but the diagnostic power of PSP for DHF is lower than NT-pro BNP. PSP may be a new marker for DHF.","PeriodicalId":315621,"journal":{"name":"E Journal of Cardiovascular Medicine","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134455515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1